Karyopharm Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
CEORichard A. Paulson
CEORichard A. Paulson
Employees279
Employees279
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees279
Employees279
KPTI Key Statistics
Market cap94.55M
Market cap94.55M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume108.51K
Average volume108.51K
High today$5.65
High today$5.65
Low today$5.41
Low today$5.41
Open price$5.60
Open price$5.60
Volume56.48K
Volume56.48K
52 Week high$13.74
52 Week high$13.74
52 Week low$3.51
52 Week low$3.51
Stock Snapshot
The current Karyopharm Therapeutics(KPTI) stock price is $5.59, with a market capitalization of 94.55M. The stock trades at a price-to-earnings (P/E) ratio of -0.38.
During the trading session on 2025-11-13, Karyopharm Therapeutics(KPTI) shares reached a daily high of $5.65 and a low of $5.41. At a current price of $5.59, the stock is +3.3% higher than the low and still -1.1% under the high.
Trading volume for Karyopharm Therapeutics(KPTI) stock has reached 56.48K, versus its average volume of 108.51K.
Over the past 52 weeks, Karyopharm Therapeutics(KPTI) stock has traded between a high of $13.74 and a low of $3.51.
Over the past 52 weeks, Karyopharm Therapeutics(KPTI) stock has traded between a high of $13.74 and a low of $3.51.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own KPTI. This list is generated using Robinhood data, and it’s not a recommendation.